LIFT vs fistulotomy for low intersphincteric fistula

lift is the sphincter-preserving option and is used to reduce fecal incontinence risk, whereas simple fistulotomy for low intersphincteric or low trans-sphincteric Crohn’s fistulas has high healing but carries a meaningful incontinence risk, especially for anterior tracts ¹. lift is not the operation for the anatomy described here, however. It works by opening the intersphincteric groove and ligating and dividing the segment of a transsphincteric tract that crosses that plane, so that the external sphincter is spared; a purely low intersphincteric fistula has no transsphincteric component to interrupt. For a low intersphincteric tract the standard operation is lay-open fistulotomy, which divides only internal sphincter and anoderm. There is in any case no direct Crohn’s comparative study here proving lift is superior for low intersphincteric fistulas ^1,2. ^1,2

What is known:

• Fistulotomy healed low Crohn’s fistulas in 81–100% in one review, but fecal incontinence was reported in up to 60% ¹; that upper figure comes from mixed Crohn’s fistula series including high and complex tracts, and incontinence risk tracks how much sphincter is divided, which is minimal for a low intersphincteric tract. ¹
• Anterior fistulas are specifically flagged as situations where fistulotomy should be avoided because of incontinence risk ¹. ¹
• Lift preserves the sphincter; reported success was about 71% pooled for complex fistulas and 33% at 1 year in a small Crohn’s series ². ²

What is unknown / caveats:

• No retrieved head-to-head Crohn’s study directly compares lift with simple fistulotomy for low intersphincteric fistulas
• Lift requires a mature, well-formed transsphincteric tract with an identifiable intersphincteric segment, and may be unsuitable in early abscessing or very complex fistulas ^1,3
• Much of the retrieved lift literature is non-Crohn or mixed-fistula data rather than isolated low intersphincteric Crohn’s disease ^4–6
• The continence advantage of lift is biologically and observationally plausible, but its trade-off against healing specifically in low intersphincteric Crohn’s fistulas is not well quantified here.

References

1. Wetwittayakhlang P, Al Khoury A, Hahn GD, Lakatos PL. The Optimal Management of Fistulizing Crohn's Disease: Evidence beyond Randomized Clinical Trials. J Clin Med. 2022;11(11). PMID: 35683433.

2. Akiba RT, Rodrigues FG, da Silva G. Management of Complex Perineal Fistula Disease. Clin Colon Rectal Surg. 2016;29(2):92-100. PMID: 27247533.

3. Scheurlen KM, MacLeod A, Kavalukas SL, Galandiuk S. State-of-the-art surgery for Crohn's disease: part III-perianal Crohn's disease. Langenbecks Arch Surg. 2023;408(1):132. PMID: 36995518.

4. Stellingwerf ME, van Praag EM, Tozer PJ, Bemelman WA, Buskens CJ. Systematic review and meta-analysis of endorectal advancement flap and ligation of the intersphincteric fistula tract for cryptoglandular and Crohn's high perianal fistulas. BJS Open. 2019;3(3):231-241. PMID: 31183438.

5. PMID: 37737881. (metadata not in corpus)

6. Al-Maawali AK, Nguyen P, Phang PT. Modern Treatments and Stem Cell Therapies for Perianal Crohn's Fistulas. Can J Gastroenterol Hepatol. 2016;2016:1651570. PMID: 28053967.

For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.

Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.